Evidence map›Paper›PMID 12578909›Full record

ArticleThe Journal of cell biology2003

Targeting of U4/U6 small nuclear RNP assembly factor SART3/p110 to Cajal bodies.

David Stanĕk, Stephen D Rader, Mirko Klingauf, Karla M Neugebauer

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 110 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Structure of the human 20S U5 snRNP.Nature structural & molecular biology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Cajal body function in genome organization and transcriptome diversity.BioEssays : news and reviews in molecular, cellular and developmental biology · 2016
    Review
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

David StanĕkMax Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany.
Stephen D Rader
Mirko Klingauf
Karla M Neugebauer
Max Planck Institute of Molecular Cell Biology and Genetics · DEUniversity of California, San Francisco · US

Funding

BIOSYNTHESIS OF RNASR01GM021119 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GUTHRIE, CHRISTINE · 1985 to 2015
$12.9M
MRNA SPLICING FACTOR BRR2F32GM018312 · NIGMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI RADER, STEPHEN D · 1996 to 1999
–
BIOSYNTHESIS OF RNASR37GM021119 · NIGMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI GUTHRIE, CHRISTINE · 1990 to 1999
–
NIGMS NIH HHS 5 F32 GM18312NIGMS NIH HHS F32 GM018312NIGMS NIH HHS GM21119NIGMS NIH HHS R01 GM021119NIGMS NIH HHS R37 GM021119
6 · The paper itself

Abstract

The spliceosomal small nuclear RNAs (snRNAs) are distributed throughout the nucleoplasm and concentrated in nuclear inclusions termed Cajal bodies (CBs). A role for CBs in the metabolism of snRNPs has been proposed but is not well understood. The SART3/p110 protein interacts transiently with the U6 and U4/U6 snRNPs and promotes the reassembly of U4/U6 snRNPs after splicing in vitro. Here we report that SART3/p110 is enriched in CBs but not in gems or residual CBs lacking coilin. The U6 snRNP Sm-like (LSm) proteins, also involved in U4/U6 snRNP assembly, were localized to CBs as well. The levels of SART3/p110 and LSm proteins in CBs were reduced upon treatment with the transcription inhibitor alpha-amanitin, suggesting that CB localization reflects active processes dependent on transcription/splicing. The NH2-terminal HAT domain of SART3/p110 was necessary and sufficient for specific protein targeting to CBs. Overexpression of truncation mutants containing the HAT domain had dominant negative effects on U6 snRNP localization to CBs, indicating that endogenous SART3/p110 plays a role in targeting the U6 snRNP to CBs. We propose that U4 and U6 snRNPs accumulate in CBs for the purpose of assembly into U4/U6 snRNPs by SART3/p110.

Indexed as

AmanitinsAnimalsAntigens, NeoplasmCell NucleusCoiled BodiesFibroblastsHeLa CellsHumansImmunohistochemistryMiceNuclear Localization SignalsNuclear ProteinsNucleic Acid Synthesis InhibitorsProtein Structure, TertiaryRecombinant Fusion ProteinsRibonucleoprotein, U4-U6 Small NuclearAmanitinsAntigens, NeoplasmNuclear Localization SignalsNuclear ProteinsNucleic Acid Synthesis Inhibitorsp80-coilinRecombinant Fusion ProteinsRibonucleoprotein, U4-U6 Small NuclearRNA-Binding ProteinsSART3 protein, human

Identifiers

PMID12578909
PMCPMC2173746
OpenAlexW2162949504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.